Tetanus Toxoid Endo-F

Total Page:16

File Type:pdf, Size:1020Kb

Tetanus Toxoid Endo-F PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/27226 Please be advised that this information was generated on 2021-09-25 and may be subject to change. 1142 G. D. Keizer, J. Borst, C. G. Figdor et al Eur. J. Immunol. 1985.15: 1142-1147 Gerrit D. Keizer0, Jannie Borst°, Biochemical and functional characteristics of the Carl G. Figdor0 , Hergen Spits0 , Frank MiedemaA, Cox TerhorstD human leukocyte membrane antigen family LFA-1, and Jan E. De Vries0 Mo-1 and pl50,95* Division of Immunology, The Netherlands Cancer Institute (Antoni The human leukocyte function-associated (LFA-1) antigen, the monocyte differentia­ van Leeuwenhoek Huis)0 , Amsterdam, tion antigen Mo-1 which is characterized as the C3bi receptor and the glycoprotein Central Laboratory of the Netherlands p i50,95 are characterized biochemically. Immunoprecipitations carried out with 6 Red Cross Blood Transfusion ServiceA, different monoclonal antibodies (mAb) against LFA-1 indicated that four mAb (SPV- Amsterdam and Dana-Farber Cancer Ll, SPV-L5, SPV-L7 and SPV-L11) were directed against the a chain, whereas mAb Institute0, Boston CLB54 and MHM-23 were found to react with the common |3 chain of LFA-1, Mo-1 and p 150,95. LFA-1 and Mo-1 expressed on KG-1 cells or lymphocytes, monocytes and granulocytes from one donor were homogeneous. Interestingly the a chain of pl50,95 showed heterogeneity. The molecular weight of the a chain expressed on monocytes was consistently higher than that of the a chain on granulocytes. The |3 subunits of LFA-1 and Mo-1 (as detected by mAb Bear-1) are not only similar in molecular weight and isoelectric focusing patterns, but it is demonstrated here that they are also identically glycosylated and have similar protein backbones as judged by tryptic peptide mapping. In spite of their structural similarities, LFA-1 and Mo-1 differ completely in some of their biological functions, Anti-LFA-1 mAb strongly inhibited monocyte-dependent T cell proliferation induced by tetanus toxoid or Helix pomatia hemocyanin and pokeweed mitogen-driven specific antibody production in vitro, whereas the anti-Mo-1 antibody Bear-1 was ineffective. These results suggest that the differences in these biological functions of LFA-1 and Mo-1 may be related to their different a subunits, which may recognize specific counter structures, 1 Introduction Mo-1, which is the receptor for the inactivated form of C3b, mediates the adhesion of soluble complexes or particles selec­ The human leukocyte function associated (LFA-1) antigen, tively opsonized with C3bi [5, 6]. The third member of this the monocyte differentiation antigen Mo-1 which is character­ family, pi50,95, is less well investigated but studies in patients ized as the C3bi receptor and the glycoprotein termed pl50,95 with an inherited LFA-1, Mo-1 and pl50,95 deficiency syn­ belong to a family of related human leukocyte membrane anti­ drome indicated that this molecule, probably similarly to gens. LFA-1 is expressed on lymphocytes, monocytes and LFA-1 and Mo-1, is associated with the adhesion of granulo- granulocytes [1], whereas Mo-1 and pl50,95 are present on cytes [7]. In addition to their functional similarities these anti­ monocytes, granulocytes and “null” cells [2], Recently, it has gens are also structurally related, Each antigen is composed of been shown that these molecules contribute to the adhesion an a and |3 subunit which are noncovalently associated. The |3 reaction of these cells. Blocking experiments with anti-LFA chains of all three molecules have a molecular mass (MM) of monoclonal antibodies (mAb) demonstrated that LFA-1 95 kDa and have been shown to be similar [8]. The a chains of inhibits the adhesion step between effector and target cells in LFA-1, Mo-l and pl50,95 have different MM of 170,165 and cytotoxic T lymphocyte, natural killer and lectin-dependent 150 kDa, respectively. cellular cytotoxicity [1, 3,4], LFA-1 also participates in mono- cyte-dependent lectin-induced T cell proliferation suggesting In the present study, 6 different mAb directed against the a or that it also acts as an adhesion molecule between monocytes |3 chain of LFA-1 were used for the biochemical characteriza­ and T cells. tion of LFA-1, Mo-1 and pl50,95 expressed on the human myeloblastic cell line KG-1. In addition, the heterogeneity of these molecules expressed on lymphocytes, monocytes and [I 5012] granulocytes derived from one donor was investigated. Our * Supported by a grant from the Koninging Wilhelmina Fonds (The findings indicate that only the a chain of pl50,95 showed Netherlands Cancer Foundation) grant no. NKI 83-19). heterogeneity. Finally we extended the findings of Sanchez- Madrid et al. [8] by demonstrating that the (3 subunits of LFA- Correspondence: Gerrit D. Keizer, Division of Immunology, The 1 and Mo-1 in addition to their similarities in MM and isoelec­ Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis), Ples- tric focusing (IEF) patterns were identically glycosylated and manlaan 121, 1066 CX Amsterdam, The Netherlands had similar protein backbones as judged by tryptic peptide mapping. In spite of these structural similarities and the fact Abbreviations: HPH: Helix pomatia hemocyanin IEF: Isoelectric that both molecules act as adhesion molecules on granulo­ focusing LFA-1: Leukocyte function-associated antigen-1 MM: cytes, it is reported here that both molecules differ completely Molecular mass mAb: Monoclonal antibody(ies) NMS: Normal mouse serum SDS: Sodium dodecyl sulfate PAGE: Polyacrylamide in other biological functions. Anti-LFA-1 antibodies strongly gel electrophoresis pfc: Preformed complex PWM: Pokeweed inhibited monocyte-dependent antigen-specific T cell prolifer­ mitogen TPA: 12-O-tetradecanoyl phorboI-13-acetate TT: Tetanus ation and pokeweed mitogen (PWM)-driven specific antibody toxoid Endo-F: Endo-p-N-acetyl-glucosaminidase F ELISA: En­ production in vitro, whereas the anti-Mo-1 antibody, Bear-1, zyme-linked immunosorbent assay RAM: Rabbit anti-mouse produced in our laboratory was ineffective. 0014-2980/85/1111-1142$02.50/0 © VCH V erlagsgesellschaft mbH, D-6940 Weinheim, 1985 Eur. J. Immunol. 1985.15: 1142-1147 Characteristics of the leukocyte membrane antigen family LFA-1, Mo-1 and pl50,95 2 Materials and methods specific mAb and rabbit anti-mouse Ig? and immunoprecipi- tates were removed from the lysates by centrifugation at 2.1 Cells 13 000 x g. Precipitates were resuspended in 0,2 ml TEA/NaCl ) buffer with 0.5% sodium deoxycholate and spun through a H u m a n leukocytes were isolated from a buffy coat from blood discontinuous gradient consisting of 0 .4 ml of 1 0 % sucrose, of healthy volunteer donors by centrifugal élutriation [9], 0.5% Nonidet-P40 in TEA/NaCl buffer, and 0.8 ml of 2 0 % M onocytes, or monocyte subsets and granulocytes obtained in sucrose in the same buffer without detergents, at 13 000 X g for this way, were >95% pure, whereas lymphocytes were 15 min. Subsequently, immunoprecipitates were washed once obtained at a purity of 99.9% [9], The myeloblastic cell line in 0.01 MTEA-HC1, pH 7,8, 0 .2 % Nonidet-P40. KG-1 [10] was maintained in RPMI 1640 containing 10% fetal calf serum, sodium pyruvate (50 mg/ml), L-glutamine 2.4 Enzyme treatment (2 X 10“3 M) and penicillin (100 IU)/streptomycin (100 [xg/ml). T his cell line was kindly provided by Dr. Robert F. Todd III Endo-p-N-acetylglucosaminidase F (Endo-F) was kindly sup­ (Dana-Farber Cancer Institute, Boston, MA). KG-1 cells plied by Drs. John Elder and Stephen Alexander (Scripps w ere stimulated with 10 ng/ml 12-O-tetradecanoyl phorbol-13- Clinic, La Jolla, CA). Endo-F treatment was performed a c e ta te (TPA, batch 028, Midland Corporation, NY) for three directly on the immune complex. The protein was resuspended days and restimulated every third day with 5 ng TP A. In this in 0.1 M sodium phosphate buffer, pH 6.1, containing 50 mM w ay adherent macrophage-like cells were obtained [11]. EDTA, 1 % 2-mercaptoethanol, 0 .1 % sodium dodecyl sulfate (SDS) and boiled for 2 min. Then, Nonidet-P40 was added to 2.2 mAb 1% and samples were incubated with Endo-F for 2 h at 37 CC, as described by Elder and Alexander [17]. T h e mAb SPV-L1, SPV-L3, SPV-L5, SPV-L7 and SPV-L11 w e re obtained by immunization of BALB/c mice with cells of 2.5 Electrophoresis and autoradiography th e T 4 +T8“ cytotoxic T lymphocyte clone HG-38 [12]. The antibodies were selected for inhibition of T cell-mediated kill­ SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was ing by screening of the hybridoma supernatants 10-14 days carried out on discontinuous vertical slab gels according to a a fte r the fusion. CLB54 (LFA-1/1) was selected in a similar modification of the Laemmli procedure [18]. Gradient gels w ay, and is directed against the (3 chain of LFA-1, Mo-1 and were made either 5-15% or 10-15% in acrylamide. Two- p!50,95 [13]. Anti-Mo-1, reactive with human monocytes, null dimensional gel electrophoresis was done in accordance with cells, granulocytes, bone marrow cells and malignant myeloid the method of O’Farrell [19]. For IEF, ampholytes (LKB, cells [2, 14], was a gift from Dr. Robert F, Todd III (Dana Bromma, Sweden) of pi 3.5-10, 4-6 and 5-8 as 1:1:4 were F a rb e r Cancer Institute, Boston, MA).
Recommended publications
  • CD27 CD70 Is Downregulated by Interaction With
    CD70 Is Downregulated by Interaction with CD27 Mirela Kuka, Ivana Munitic, Maria Letizia Giardino Torchia and Jonathan D. Ashwell This information is current as of September 25, 2021. J Immunol 2013; 191:2282-2289; Prepublished online 2 August 2013; doi: 10.4049/jimmunol.1300868 http://www.jimmunol.org/content/191/5/2282 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2013/08/06/jimmunol.130086 Material 8.DC1 References This article cites 35 articles, 19 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/191/5/2282.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 25, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology CD70 Is Downregulated by Interaction with CD27 Mirela Kuka,1,2 Ivana Munitic,1,3 Maria Letizia Giardino Torchia, and Jonathan D. Ashwell Engagement of the receptor CD27 by CD70 affects the magnitude and quality of T cell responses in a variety of infection models, and exaggerated signaling via this pathway results in enhanced immune responses and autoimmunity.
    [Show full text]
  • 7432.Full.Pdf
    CD27 Is Acquired by Primed B Cells at the Centroblast Stage and Promotes Germinal Center Formation This information is current as Yanling Xiao, Jenny Hendriks, Petra Langerak, Heinz Jacobs of September 29, 2021. and Jannie Borst J Immunol 2004; 172:7432-7441; ; doi: 10.4049/jimmunol.172.12.7432 http://www.jimmunol.org/content/172/12/7432 Downloaded from References This article cites 43 articles, 23 of which you can access for free at: http://www.jimmunol.org/content/172/12/7432.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 29, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology CD27 Is Acquired by Primed B Cells at the Centroblast Stage and Promotes Germinal Center Formation1 Yanling Xiao, Jenny Hendriks, Petra Langerak, Heinz Jacobs, and Jannie Borst2 Studies on human B cells have featured CD27 as a marker and mediator of the B cell response.
    [Show full text]
  • Uva-DARE (Digital Academic Repository)
    UvA-DARE (Digital Academic Repository) Contributions of CD27 and relatives to the specific immune response Hendriks, J.A. Publication date 2004 Link to publication Citation for published version (APA): Hendriks, J. A. (2004). Contributions of CD27 and relatives to the specific immune response. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:24 Sep 2021 Chapter 5 CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation. Yanling Xiao, Jenny Hendriks, Petra Langerak, Heinz Jacobs and Jannie Borst The Journal of Immunology 2004 172: 7432-7441 67 68 CD27 Is Acquired by Primed B Cells at the Centroblast Stage and Promotes Germinal Center Formation1 Yanling Xiao, Jenny Hendriks, Petra Langerak, Heinz Jacobs, and Jannie Borst2 Studies on human B cells have featured CD27 as a marker and mediator of the B cell response.
    [Show full text]
  • Uva-DARE (Digital Academic Repository)
    UvA-DARE (Digital Academic Repository) Molecular basis of CD4+ T cell help for the cytotoxic T cell response Ahrends, T.J. Publication date 2018 Document Version Other version License Other Link to publication Citation for published version (APA): Ahrends, T. J. (2018). Molecular basis of CD4+ T cell help for the cytotoxic T cell response. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:08 Oct 2021 CURRICULUM VITAE LIST OF PUBLICATIONS & WORD OF THANKS ADDENDUM CURRICULUM VITAE Tomasz Ahrends was born on December 30th, 1988 in Gdańsk (Poland). In 2010 he obtained Bachelor’s degree in Biotechnology at the Intercollegiate Faculty of Biotechnology of University of Gdańsk and Medical University of Gdańsk. Subsequently, he continued his education with a Master’s degree in Biotechnology, which he fnished in 2012.
    [Show full text]
  • PDF Hosted at the Radboud Repository of the Radboud University Nijmegen
    PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/27226 Please be advised that this information was generated on 2021-09-26 and may be subject to change. 1142 G. D. Keizer, J. Borst, C. G. Figdor et al Eur. J. Immunol. 1985.15: 1142-1147 Gerrit D. Keizer0, Jannie Borst°, Biochemical and functional characteristics of the Carl G. Figdor0 , Hergen Spits0 , Frank MiedemaA, Cox TerhorstD human leukocyte membrane antigen family LFA-1, and Jan E. De Vries0 Mo-1 and pl50,95* Division of Immunology, The Netherlands Cancer Institute (Antoni The human leukocyte function-associated (LFA-1) antigen, the monocyte differentia­ van Leeuwenhoek Huis)0 , Amsterdam, tion antigen Mo-1 which is characterized as the C3bi receptor and the glycoprotein Central Laboratory of the Netherlands p i50,95 are characterized biochemically. Immunoprecipitations carried out with 6 Red Cross Blood Transfusion ServiceA, different monoclonal antibodies (mAb) against LFA-1 indicated that four mAb (SPV- Amsterdam and Dana-Farber Cancer Ll, SPV-L5, SPV-L7 and SPV-L11) were directed against the a chain, whereas mAb Institute0, Boston CLB54 and MHM-23 were found to react with the common |3 chain of LFA-1, Mo-1 and p 150,95. LFA-1 and Mo-1 expressed on KG-1 cells or lymphocytes, monocytes and granulocytes from one donor were homogeneous. Interestingly the a chain of pl50,95 showed heterogeneity. The molecular weight of the a chain expressed on monocytes was consistently higher than that of the a chain on granulocytes.
    [Show full text]
  • Radio-Immunotherapy in Cancer
    Radio-immunotherapy in cancer Inge Verbrugge The Netherlands Cancer Institute Radiotherapy • One of three /four main treatment modalities • Used in ~50% of cancer patients • Administered locally: minimizes normal tissue damage Effects of radiotherapy on tumor cell clonogenicity DNA damage 1. (Irreversible) cell cycle arrest senescence 2. Death due to mitotic catastrophe 3. Apoptotic cell death Radiotherapy alone may not be curative RADIOTHERAPY Curing metastasized cancer with systemic therapy • Immunotherapy - Eliciting systemic anti-tumor cytotoxic T cell (CTL) responses (CTL) MHC I Radiotherapy: Clinical systemic (=‘abscopal’) responses Pre-radiotherapy Post-radiotherapy ‘Abscopal Effect’ Ohba K et al., Gut 1998;43:575-577 Radiotherapy may support local and systemic tumor immunity Radiotherapy may support local and systemic tumor immunity Co-stimulation ‘abscopal effect’ Established tumors evade immune responses Bottlenecks 1. Lack of recognizable ‘tumor’ antigens 2. Lack of ‘danger signals’ 3. Lack of T cell infiltration into tumor 4. Inhibition CTL activity by tumor / tumor micro-environment Antibodies modulating T cell responses Ipilimumab Pembrolizumab Nivolumab Mellman I et al., Nature 2011;480:480-489 Antibodies modulating T cell responses Ipilimumab Pembrolizumab Nivolumab Mellman I et al., Nature 2011;480:480-489 Antibody-based immunotherapy: local and systemic effects Co-inhibitory receptor Co-stimulatory receptor Radio-immunotherapy: Combining radiotherapy with immunotherapy Blocking coinhibition α-PD-1, α-CD137 Costimulation Radio-immunotherapy promise: Achieving SYSTEMIC synergism by combining LOCAL radiotherapy with immune-modulation Radio-immunotherapy: opportunities Blocking coinhibition α-PD-1, α-CD137 Costimulation 1. Inducing curative local combined responses 2. Achieving systemic combined effect by promoting relevant immune responses Radio-immunotherapy induces local tumor control α-PD-1 α-PD-1, α-CD137 α-CD137 Achieving systemic combined effects by radio-immunotherapy Blocking coinhibition α-PD-1, α-CD137 Costimulation 2.
    [Show full text]
  • Effector T Cell Pool + CD8 Costimulation to Promote
    CD8+ T Cells Produce the Chemokine CXCL10 in Response to CD27/CD70 Costimulation To Promote Generation of the CD8 + Effector T Cell Pool This information is current as of October 2, 2021. Victor Peperzak, Elise A. M. Veraar, Yanling Xiao, Nikolina Babala, Klaske Thiadens, Marieke Brugmans and Jannie Borst J Immunol 2013; 191:3025-3036; Prepublished online 12 August 2013; Downloaded from doi: 10.4049/jimmunol.1202222 http://www.jimmunol.org/content/191/6/3025 Supplementary http://www.jimmunol.org/content/suppl/2013/08/12/jimmunol.120222 http://www.jimmunol.org/ Material 2.DC1 References This article cites 56 articles, 29 of which you can access for free at: http://www.jimmunol.org/content/191/6/3025.full#ref-list-1 Why The JI? Submit online. by guest on October 2, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology CD8+ T Cells Produce the Chemokine CXCL10 in Response to CD27/CD70 Costimulation To Promote Generation of the CD8+ Effector T Cell Pool Victor Peperzak,1 Elise A.
    [Show full text]
  • Pulling the Strings on Anti-Cancer Immunity Issue Date: 2017-02-07
    Cover Page The handle http://hdl.handle.net/1887/45885 holds various files of this Leiden University dissertation. Author: Kersten, K. Title: Pulling the strings on anti-cancer immunity Issue Date: 2017-02-07 Pulling the strings on anti-cancer immunity Kelly Kersten About the cover: Based on the research described in this thesis and inspired by the song ‘Master of Puppets’ by Metallica, I envision cancer as a puppet-master restraining the protective function of the immune system. Part of my PhD work has focused on how tumor cells manipulate the function of immune cells to favor their spread throughout the body. In other words, cancer is pulling the strings on anti-cancer immunity to prevent destruction by the immune system. With the recent advances of combinatorial anti-cancer therapies (including immunomodulatory drugs) we can gain back control over the strings on anti-cancer immunity. Cover design: Kelly Kersten & Tomasz Ahrends Artwork: Tomasz Ahrends Lay-out: Jasper Koning ([email protected]) Printing: Gildeprint, Enschede ISBN: 978-94-6233-496-0 The printing of the thesis was financially supported by the NKI-AVL. ©2016 by Kelly Kersten. All rights reserved. No part of this thesis may be reproduced, stored in a retrieval system, or transmitted in any form or by any means without prior permission of the author and the publisher holding the copyright of the articles. The research described in this thesis was performed at the Divisions of Molecular Biology and Immunology of the Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, The Netherlands, and was supported by the Dutch Cancer Society (KWF2011-5004) and the European Research Council (InflaMet 615300).
    [Show full text]
  • Differentiation Antigens of Human Hemopoietic Cells: Patterns of Reactivity of Two Monoclonal Antibodies1
    [CANCER RESEARCH 43, 4812-4815, October 1983] Differentiation Antigens of Human Hemopoietic Cells: Patterns of Reactivity of Two Monoclonal Antibodies1 Silvana Passano,2 Lisabianca Bùttero, Jeffrey Faust, Massimo Trucco, Antonio Palumbo, Luigi Pegoraro, Beverly Lange, Colette Brezin, Jannie Borst, Cox Terhorst, and Giovanni Rovera The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104 [S. P., L. B., J. F., M. T., A. P., G. R.]; The Institute of Internal Medicine, University of Turin, Italy [L. P.]; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 [B. L); and The Dana-Farber Cancer Institute, Boston, Massachusetts 02115 [C. B., J. B., C. T.] ABSTRACT terized the surface antigens recognized by 2 monoclonal anti bodies generated by immunizing mice with AML cells. These Two mouse anti-human monoclonal antibodies (S3.13 and antibodies are reactive with a large number of leukemic cell lines S5.7) raised against cells of acute myelogenous leukemia were and have a complex distribution on hemopoietic cells. found to react with antigens expressed on the surface of subsets of monocytes and lymphocytes. MATERIALS AND METHODS S3.13 precipitates a peptide of M, 29,000, and S5.7 precipi tates a peptide of M, 20,000 present on the surface of all the cell Hemopoietic Tissues. Normal peripheral blood and marrow for these types tested. These two surface antigens were distributed on investigations were obtained from healthy volunteer donors and ap proved by the Committee for the Protection of Human Subjects of The discrete subpopulations of normal hemopoietic cells. The anti Wistar Institute. bodies reacted with all (S5.7) or a subpopulation (S3.13) of Mononuclear cells were separated by FicolhHypaque (D = 1.078) peripheral blood T-lymphocytes, and with a subset of monocytes.
    [Show full text]
  • GPA33: a Marker to Identify Stable Human Regulatory T Cells
    The Journal of Immunology GPA33: A Marker to Identify Stable Human Regulatory T Cells Rianne Opstelten,* Sander de Kivit,†,1 Manon C. Slot,* Maartje van den Biggelaar,‡ Dorota Iwaszkiewicz-Grzes,x Mateusz Gliwin´ski,x Andrew M. Scott,{ Bianca Blom,‖ Piotr Trzonkowski,x Jannie Borst,†,1 Eloy Cuadrado,* and Derk Amsen* FOXP3-expressing regulatory T (Treg) cells safeguard immunological tolerance. Treg cells can be generated during thymic development (called thymic Treg [tTreg] cells) or derived from mature conventional CD4+ T cells that underwent TGF-b– mediated conversion in the periphery (called peripheral Treg [pTreg] cells). Murine studies have shown that tTreg cells exhibit strong lineage fidelity, whereas pTreg cells can revert into conventional CD4+ T cells. Their stronger lineage commitment makes tTreg cells the safest cells to use in adoptive cell therapy, increasingly used to treat autoimmune and inflammatory disorders. Markers to distinguish human tTreg cells from pTreg cells have, however, not been found. Based on combined proteomic and transcriptomic approaches, we report that the Ig superfamily protein GPA33 is expressed on a subset of human Treg cells. GPA33 is acquired late during tTreg cell development but is not expressed on TGF-b–induced Treg cells. GPA33 identifies Treg cells in human blood that lack the ability to produce effector cytokines (IL-2, IFN-g, IL-17), regardless of differentiation stage. GPA33high Treg cells universally express the transcription factor Helios that preferentially marks tTreg cells and can robustly and stably be expanded in vitro even without rapamycin. Expanded GPA33high Treg cells are suppressive, unable to produce proinflammatory cytokines, and exhibit the epigenetic modifications of the FOXP3 gene enhancer CNS2, necessary for indelible expression of this critical transcription factor.
    [Show full text]
  • CD70 As an Actionable Immunotherapeutic Target in Recurrent Glioblastoma
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.02.446670; this version posted June 2, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Hitting more birds with one stone: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma 1* 2* 1 2 1 2 Seyfrid M , Maich W , Shaikh MV ,Tatari N , Upreti D , Piyasena D , Subapanditha M1, Savage N2, McKenna D1, Kuhlmann L 3, Khoo A3, Salim SK2, Bassey-Archibong B1, Gwynne W1, Chokshi C 2, Brown K4, Murtaza N2, Bakhshinyan D2, Vora P1, Venugopal C1, Moffat J4, Singh SK1,2. *These authors made equal contributions to this paper Departments of 1Surgery, 2Biochemistry and Biomedical Sciences, Faculty of Health Sciences, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada 3Princess Margaret’s Hospital, Toronto, Ontario, M5S 3E1, Canada 4Donnelly Centre, Department of Molecular Genetics, University of Toronto, Ontario, Canada RUNNING TITLE CD70 as an immunotherapeutic for recurrent GBM KEYWORDS: Glioblastoma, CD70, Immunotherapy, CAR-T CONFLICTS OF INTEREST: This work was partly funded by Longbow Therapeutics (company no longer in existence) 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.06.02.446670; this version posted June 2, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
    [Show full text]
  • CD27 Sustains Survival of Ctls in Virus-Infected Nonlymphoid Tissue in Mice by Inducing Autocrine IL-2 Production
    CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production Victor Peperzak, … , Elise A.M. Veraar, Jannie Borst J Clin Invest. 2010;120(1):168-178. https://doi.org/10.1172/JCI40178. Research Article Immunology Immunity to infections relies on clonal expansion of CD8+ T cells, their maintenance as effector CTLs, and their selection into a memory population. These processes rely on delivery of survival signals to activated CD8+ T cells. We here reveal the mechanism by which costimulatory CD27-CD70 interactions sustain survival of CD8+ effector T cells in infected tissue. By unbiased genome-wide gene expression analysis, we identified the Il2 gene as the most prominent CD27 target gene in murine CD8+ T cells. In vitro, CD27 directed IL-2 expression and promoted clonal expansion of primed CD8+ T cells exclusively by IL-2–dependent survival signaling. In mice intranasally infected with influenza virus,C d27–/– CD8+ effector T cells displayed reduced IL-2 production, accompanied by impaired accumulation in lymphoid organs and in the lungs, which constitute the tissue effector site. Reconstitution of Cd27–/– CD8+ T cells with the IL2 gene restored their accumulation to wild-type levels in the lungs, but it did not rescue their accumulation in lymphoid organs. Competition experiments showed that the IL-2 produced under the control of CD27 supported effector CD8+ T cell survival in the lungs in an autocrine manner. We conclude that CD27 signaling directs the IL-2 production that is reportedly essential to sustain survival of virus-specific CTLs in nonlymphoid tissue.
    [Show full text]